Research & Development

Solvotrin Therapeutics was incorporated after the discovery of lead a platform of salicylate and niacin pro-drugs, which are backed by a family of granted and pending patents.

This platform has applications in inflammatory diseases, cholesterol problems and cancer. The company also has a platform of novel nitrate-releasing tetracyclines which are focused on inflammatory diseases.